ArticleMolecular cancer therapeutics2013

YM-155 potentiates the effect of ABT-737 in malignant human glioma cells via survivin and Mcl-1 downregulation in an EGFR-dependent context.

Esther P Jane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.